Undifferentiated systemic rheumatic (connective tissue) diseases and overlap syndromes
- Richard S Panush, MD, MACP, MACR
Richard S Panush, MD, MACP, MACR
- Professor of Medicine, Division of Rheumatology
- Keck School of Medicine, University of Southern California
- Neil Kramer, MD, FACR, FACP
Neil Kramer, MD, FACR, FACP
- Director, Institute for Rheumatic and Autoimmune Diseases
- Overlook Medical Center, Summit, NJ
- Elliot D Rosenstein, MD, FACR, FACP
Elliot D Rosenstein, MD, FACR, FACP
- Director, Institute for Rheumatic & Autoimmune Diseases
- Overlook Medical Center, Summit, NJ
- Professor of Medicine, Division of Rheumatology
- Sidney Kimmel Medical College at Thomas Jefferson University
As much as 25 percent of rheumatic disease patients with systemic symptoms cannot be definitively diagnosed [1,2]. Furthermore, the majority of these patients will remain undiagnosed during 5 to 10 years of follow-up. Such patients were historically described as having “collagen” or “connective tissue” diseases, since they shared similar clinical and pathologic features of widespread inflammation [3-5]. Subsequently, these patients have been considered to have “diffuse” or “undifferentiated” (or sometimes “early undifferentiated”) “connective tissue diseases” (UCTD) [6-11]. Other patients with rheumatic diseases have systemic features that overlap two or more specific, recognized entities and also cannot be definitively diagnosed [2,12-14].
Increasingly, the term “systemic rheumatic” disease has replaced “collagen,” “collagen-vascular,” or “connective tissue” disease. This change reflects the recognition that these disorders probably represent perturbations of the immune system with resultant inflammatory tissue injury rather than primary disorders of collagen, vasculature, or connective tissue; the inciting events are not yet clear.
This topic review provides an overview of undifferentiated systemic rheumatic diseases and overlap disorders, together with an overall approach to the patient.
The American College of Rheumatology (ACR) and the European League Against Rheumatism (EULAR) have developed classification criteria to assist in the categorization and diagnosis of patients with rheumatic diseases. These classification criteria do not substitute for identification of unique, defining etiologic, clinical, or immunopathologic features for systemic rheumatic diseases, which remain unknown for most of these disorders.
The disorders generally considered to be undifferentiated systemic rheumatic diseases (USRD) and/or overlap syndromes are presented in the table (table 1). Undifferentiated rheumatic diseases generally comprise one or more of the following clinical scenarios:
- Dubois EL, Wallace DJ. Differential diagnosis. In: Dubois' Lupus Erythematosus, Wallace DJ, Dubois EL (Eds), Lea and Febiger, Philadelphia 1987. p.470.
- Cervera R, Khamashta MA, Hughes GR. 'Overlap' syndromes. Ann Rheum Dis 1990; 49:947.
- Klemperer P. The concept of collagen diseases in medicine. Am Rev Respir Dis 1961; 83:331.
- Klemperer P. The concept of connective-tissue disease. Circulation 1962; 25:869.
- Doria A, Mosca M, Gambari PF, Bombardieri S. Defining unclassifiable connective tissue diseases: incomplete, undifferentiated, or both? J Rheumatol 2005; 32:213.
- LeRoy EC, Maricq HR, Kahaleh MB. Undifferentiated connective tissue syndromes. Arthritis Rheum 1980; 23:341.
- Kallenberg CG. Overlapping syndromes, undifferentiated connective tissue disease, and other fibrosing conditions. Curr Opin Rheumatol 1993; 5:809.
- Alarcón GS, Williams GV, Singer JZ, et al. Early undifferentiated connective tissue disease. I. Early clinical manifestation in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of well established connective tissue disease. J Rheumatol 1991; 18:1332.
- Clegg DO, Williams HJ, Singer JZ, et al. Early undifferentiated connective tissue disease. II. The frequency of circulating antinuclear antibodies in patients with early rheumatic diseases. J Rheumatol 1991; 18:1340.
- Bulpitt KJ, Clements PJ, Lachenbruch PA, et al. Early undifferentiated connective tissue disease: III. Outcome and prognostic indicators in early scleroderma (systemic sclerosis). Ann Intern Med 1993; 118:602.
- Alarcón GS, Willkens RF, Ward JR, et al. Early undifferentiated connective tissue disease. IV.Musculoskeletal manifestations in a large cohort of patients with undifferentiated connective tissue diseases compared with cohorts of patients with well-established connective tissue diseases: followup analyses in patients with unexplained polyarthritis and patients with rheumatoid arthritis at baseline. Arthritis Rheum 1996; 39:403.
- Panush RS, Greer JM, Morshedian KK. What is lupus? What is not lupus? Rheum Dis Clin North Am 1993; 19:223.
- Greer JM, Panush RS. Incomplete lupus erythematosus. Arch Intern Med 1989; 149:2473.
- Panush RS, Edwards NL, Longley S, Webster E. 'Rhupus' syndrome. Arch Intern Med 1988; 148:1633.
- Hadler NM. The pall of persistence. In: Stabbed in the Back: Confronting Back Pain in an Overtreated Society, UNC Press, Chapel Hill 2009. p.23.
- Edwards JC. Diagnostic categories in rheumatology. Ann Rheum Dis 1987; 46:259.
- Jones R, Barraclough K, Dowrick C. When no diagnostic label is applied. BMJ 2010; 340:c2683.
- Costenbader KH, Schur PH. We need better classification and terminology for "people at high risk of or in the process of developing lupus". Arthritis Care Res (Hoboken) 2015; 67:593.
- Chikura B, Moore T, Manning J, et al. Thumb involvement in Raynaud's phenomenon as an indicator of underlying connective tissue disease. J Rheumatol 2010; 37:783.
- Meli M, Gitzelmann G, Koppensteiner R, Amann-Vesti BR. Predictive value of nailfold capillaroscopy in patients with Raynaud's phenomenon. Clin Rheumatol 2006; 25:153.
- Kallenberg CG. Early detection of connective tissue disease in patients with Raynaud's phenomenon. Rheum Dis Clin North Am 1990; 16:11.
- Landry GJ, Edwards JM, McLafferty RB, et al. Long-term outcome of Raynaud's syndrome in a prospectively analyzed patient cohort. J Vasc Surg 1996; 23:76.
- Kallenberg CG, Wouda AA, Hoet MH, van Venrooij WJ. Development of connective tissue disease in patients presenting with Raynaud's phenomenon: a six year follow up with emphasis on the predictive value of antinuclear antibodies as detected by immunoblotting. Ann Rheum Dis 1988; 47:634.
- Wolfe F, Ross K, Hawley DJ, et al. The prognosis of rheumatoid arthritis and undifferentiated polyarthritis syndrome in the clinic: a study of 1141 patients. J Rheumatol 1993; 20:2005.
- Hitchon CA, Peschken CA, Shaikh S, El-Gabalawy HS. Early undifferentiated arthritis. Rheum Dis Clin North Am 2005; 31:605.
- Marzo-Ortega H, Cawkwell L, Green MJ. Early oligoarthritis. Rheum Dis Clin North Am 2005; 31:627.
- Jansen LM, van Schaardenburg D, van der Horst-Bruinsma IE, Dijkmans BA. One year outcome of undifferentiated polyarthritis. Ann Rheum Dis 2002; 61:700.
- van Aken J, van Dongen H, le Cessie S, et al. Comparison of long term outcome of patients with rheumatoid arthritis presenting with undifferentiated arthritis or with rheumatoid arthritis: an observational cohort study. Ann Rheum Dis 2006; 65:20.
- van Dongen H, van Aken J, Lard LR, et al. Efficacy of methotrexate treatment in patients with probable rheumatoid arthritis: a double-blind, randomized, placebo-controlled trial. Arthritis Rheum 2007; 56:1424.
- van der Helm-van Mil AH, le Cessie S, van Dongen H, et al. A prediction rule for disease outcome in patients with recent-onset undifferentiated arthritis: how to guide individual treatment decisions. Arthritis Rheum 2007; 56:433.
- van Gaalen FA, Linn-Rasker SP, van Venrooij WJ, et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004; 50:709.
- Le Loët X, Brazier M, Mejjad O, et al. Serum IgA rheumatoid factor and pyridinoline in very early arthritis as predictors of erosion(s) at two years: a simple model of prediction from a conservatively treated community-based inception cohort. Arthritis Care Res (Hoboken) 2010; 62:1739.
- Tamai M, Kawakami A, Uetani M, et al. A prediction rule for disease outcome in patients with undifferentiated arthritis using magnetic resonance imaging of the wrists and finger joints and serologic autoantibodies. Arthritis Rheum 2009; 61:772.
- Emad Y, Ragab Y, Shaarawy A, et al. Can magnetic resonance imaging differentiate undifferentiated arthritis based on knee imaging? J Rheumatol 2009; 36:1963.
- Sampaio-Barros PD, Bortoluzzo AB, Conde RA, et al. Undifferentiated spondyloarthritis: a longterm followup. J Rheumatol 2010; 37:1195.
- Aletaha D, Neogi T, Silman AJ, et al. 2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann Rheum Dis 2010; 69:1580.
- Aletaha D, Neogi T, Silman AJ, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62:2569.
- Krabben A, Huizinga TW, van der Helm-van Mil AH. Undifferentiated arthritis characteristics and outcomes when applying the 2010 and 1987 criteria for rheumatoid arthritis. Ann Rheum Dis 2012; 71:238.
- Cheng W, Gilliam AC, Castrovinci A, Pazirandeh M. Anti-thyroid autoantibody-associated interface dermatitis in individuals with undifferentiated connective tissue disease--an unrecognized subset of autoimmune disease? J Rheumatol 2007; 34:81.
- de Lauretis A, Veeraraghavan S, Renzoni E. Review series: Aspects of interstitial lung disease: connective tissue disease-associated interstitial lung disease: how does it differ from IPF? How should the clinical approach differ? Chron Respir Dis 2011; 8:53.
- Kinder BW, Collard HR, Koth L, et al. Idiopathic nonspecific interstitial pneumonia: lung manifestation of undifferentiated connective tissue disease? Am J Respir Crit Care Med 2007; 176:691.
- Homma Y, Ohtsuka Y, Tanimura K, et al. Can interstitial pneumonia as the sole presentation of collagen vascular diseases be differentiated from idiopathic interstitial pneumonia? Respiration 1995; 62:248.
- Fischer A, West SG, Swigris JJ, et al. Connective tissue disease-associated interstitial lung disease: a call for clarification. Chest 2010; 138:251.
- Fischer A, Antoniou KM, Brown KK, et al. An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features. Eur Respir J 2015; 46:976.
- Ferri C, Manfredi A, Sebastiani M, et al. Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature. Autoimmun Rev 2016; 15:61.
- Satoh M, Chan EK, Sobel ES, et al. Clinical implication of autoantibodies in patients with systemic rheumatic diseases. Expert Rev Clin Immunol 2007; 3:721.
- Mosca M, Tani C, Bombardieri S. Undifferentiated connective tissue diseases (UCTD): a new frontier for rheumatology. Best Pract Res Clin Rheumatol 2007; 21:1011.
- Williams HJ, Alarcón GS, Neuner R, et al. Early undifferentiated connective tissue disease. V. An inception cohort 5 years later: disease remissions and changes in diagnoses in well established and undifferentiated connective tissue diseases. J Rheumatol 1998; 25:261.
- Williams HJ, Alarcon GS, Joks R, et al. Early undifferentiated connective tissue disease (CTD). VI. An inception cohort after 10 years: disease remissions and changes in diagnoses in well established and undifferentiated CTD. J Rheumatol 1999; 26:816.
- Danieli MG, Fraticelli P, Franceschini F, et al. Five-year follow-up of 165 Italian patients with undifferentiated connective tissue diseases. Clin Exp Rheumatol 1999; 17:585.
- Bodolay E, Csiki Z, Szekanecz Z, et al. Five-year follow-up of 665 Hungarian patients with undifferentiated connective tissue disease (UCTD). Clin Exp Rheumatol 2003; 21:313.
- Guerrero LF, Rueda JC, Arciniegas R, Rueda JM. Undifferentiated connective tissue disease in a rheumatology center in Cali, Colombia: clinical features of 94 patients followed for a year. Rheumatol Int 2013; 33:1085.
- Mosca M, Tani C, Vagnani S, et al. The diagnosis and classification of undifferentiated connective tissue diseases. J Autoimmun 2014; 48-49:50.
- Mosca M, Tavoni A, Neri R, et al. Undifferentiated connective tissue diseases: the clinical and serological profiles of 91 patients followed for at least 1 year. Lupus 1998; 7:95.
- Mosca M, Neri R, Bencivelli W, et al. Undifferentiated connective tissue disease: analysis of 83 patients with a minimum followup of 5 years. J Rheumatol 2002; 29:2345.
- Cavazzana I, Franceschini F, Belfiore N, et al. Undifferentiated connective tissue disease with antibodies to Ro/SSa: clinical features and follow-up of 148 patients. Clin Exp Rheumatol 2001; 19:403.
- Belfiore N, Rossi S, Bobbio-Pallavicini F, et al. Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease. Joint Bone Spine 2000; 67:183.
- Rodríguez-Reyna TS, Alarcón-Segovia D. Overlap syndromes in the context of shared autoimmunity. Autoimmunity 2005; 38:219.
- Amezcua-Guerra LM, Springall R, Marquez-Velasco R, et al. Presence of antibodies against cyclic citrullinated peptides in patients with 'rhupus': a cross-sectional study. Arthritis Res Ther 2006; 8:R144.
- Wise CM, Vuyyuru S, Roberts WN. Methotrexate in nonrenal lupus and undifferentiated connective tissue disease--a review of 36 patients. J Rheumatol 1996; 23:1005.
- Zold E, Szodoray P, Nakken B, et al. Alfacalcidol treatment restores derailed immune-regulation in patients with undifferentiated connective tissue disease. Autoimmun Rev 2011; 10:155.